Families affected by ultra-rare diseases are starting their own companies to speed up the development of treatments for their children, venturing into territory that traditional drugmakers deem too risky. Read More
Source link
Families affected by ultra-rare diseases are starting their own companies to speed up the development of treatments for their children, venturing into territory that traditional drugmakers deem too risky. Read More
Source link